Iovance Biotherapeutics Appoints Matthew Rosinack As Interim Principal Financial Officer
ReutersJul 3, 2025 8:10 PM
July 3 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:
IOVANCE BIOTHERAPEUTICS INC - MATTHEW ROSINACK APPOINTED INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
George Soros’s Playbook in 2025: Opportunistic, Nimble, and Undeniably Contrarian
TradingKey - When ordinary investors hear George Soros's name, it evokes that hedge fund legend who “broke the Bank of England,” but today Soros Fund Management trades with a system that is far more complicated than speculating in currencies.TradingKey
7 hours ago
[Reuters Analysis] US fiscal folly could create big, beautiful debt spiral: Klement
LONDON, July 3 (Reuters) - The U.S. tax and spending bill passed on July 3 is expected to add more than $3 trillion to the country’s deficit over the next decade. If the current debt trajectory continues unabated, it could set off a slow motion debt spiral that could endanger ...Reuters
8 hours ago
Oscar Health’s Unexpected Profit Surge
TradingKey - Oscar Health (OSCR) assembled an unlikely reversal with 42% YoY revenue growth to $3.05 billion in Q1 2025 and net income of $275 million, which represents a remarkable $98 million year-over-year improvement.TradingKey
23 hours ago
.jpg)
Prediction! Federal Reserve Chairman Jerome Powell's Next Move Will Be an Interest Rate Cut
The Federal Reserve must balance the risks of higher inflation with the risks of higher unemployment when making decisions on interest rates.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were..The Motley Fool
Thu, Jun 26
Will Trump’s Tax Bill Benefit American Citizens? 3 Major Controversies: SALT, Medicaid Cuts, and Fiscal Deficits
TradingKey - Key questions remain: Does the U.S. still have room for further tax cuts amid its massive fiscal deficit? Will adjustments to the State and Local Tax (SALT) cap truly benefit ordinary Americans or merely enrich the wealthy? Can Congress and society accept the welfare cuts? Will the...TradingKey
Fri, May 23
Tradingkey
